Disseminated intravascular coagulation among pregnant patients with COVID-19

Video

Jeanette Carpenter, MD, MSCI, maternal-fetal medicine specialist at Pediatrix Medical Group, discussed a recently published study regarding pregnant COVID-19 patients who also had disseminated intravascular coagulation (DIC).

Jeanette Carpenter, MD, MSCI, maternal-fetal medicine specialist at Pediatrix Medical Group, based out of Salt Lake City, Utah, discussed a recently published study regarding pregnant COVID-19 patients who also had disseminated intravascular coagulation (DIC). DIC is a serious condition that can cause the depletion of blood clotting factors and lead to hemorrhage among other complications.

Recent Videos
Radon exposure linked to increased risk of gestational diabetes | Image Credit: publichealth.columbia.edu.
Dr. Thomas outlines the future of the Safe Baby Safe Moms program | Image Credit: medstarhealth.org.
How the Safe Baby Safe Moms program transforms maternal and child health | Image Credit: medstarhealth.org.
COVID-19 Therapy Roundtable: Focusing on inpatient care
COVID-19 Therapy Roundtable: Defining the virus today and treatment options
March of Dimes 2024 Report highlights preterm birth crisis | Image Credit: marchofdimes.org
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Related Content
© 2025 MJH Life Sciences

All rights reserved.